CNBC January 17, 2024
Kif Leswing,Rohan Goswami

Key Points

– A federal appeals court will allow a ban on Apple Watch Series 9 sales to resume on Thursday.

– A patent dispute between Apple and technology company Masimo over blood oxygen senor technology has intermittently disrupted sales of Apple’s latest smart watch.

– The resumed ban does not resolve Apple’s appeal to overturn the International Trade Commission’s decision.

Apple will again be barred from selling watches with blood oxygen sensors beginning Thursday, the U.S. Court of Appeals for the Federal Circuit said.

The court order Wednesday did not rule on Apple’s effort to overturn a U.S. International Trade Commission ban on the company selling the affected watches in the United States. But it lifted an injunction that...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Technology, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article